NCT00405327View on ClinicalTrials.gov

A Pilot Study of Tumor Cell Vaccine for High-risk Solid Tumor Patients Following Stem Cell Transplantation

PHASE2CompletedINTERVENTIONAL
Enrollment

16

Participants

Timeline

Start Date

June 30, 2006

Primary Completion Date

June 30, 2009

Study Completion Date

June 30, 2010

Conditions
SarcomaNeuroblastomaWilm's Tumor
Interventions
BIOLOGICAL

Tumor lysate-pulsed dendritic cell (DC) vaccine

Tumor lysate-pulsed dendritic cell vaccine

OTHER

Hematopoietic stem cell transplantation (HSCT)

Hematopoietic stem cell transplantation (HSCT)

Trial Locations (1)

48170

University of Michigan, Department of Surgery, Pediatric Section, Ann Arbor

All Listed Sponsors
lead

University of Michigan Rogel Cancer Center

OTHER

NCT00405327 - A Pilot Study of Tumor Cell Vaccine for High-risk Solid Tumor Patients Following Stem Cell Transplantation | Biotech Hunter | Biotech Hunter